Annual Report Searches
Alphabetical Search
SYMBOL SEARCH RESULTS: RNST
Total Results: 1
RENASANT CORP (RNST:NASDAQ)
Current Annual Report in Stock

Advertisement
LEXICON PHARMACEUTICALS INC (LXRX:NASDAQ)
Lexicon is a biopharmaceutical company focused on developing breakthrough treatments for human disease. Lexicon has clinical-stage drug programs for diabetes, carcinoid syndrome, and other indications, all of which were discovered by Lexicon's research team. Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.

Yearly Figures

(in thousands, except per share amounts)
FYE: 12/31 2013 2012 2011 2010
Net Revenues $2,222 $1,089 $1,849 $4,908
Net Income (Loss) ($104,126) ($110,211) ($116,215) ($101,775)
Earnings Per Share (0.2) (0.23) (0.34) (0.34)

Quarterly Figures

(in thousands, except per share amounts)
              Third Quarter
FYE: 12/31 9/30/14 9/30/13
Net Revenues $419 $238
Net Income (Loss) ($40,498) ($31,658)
Earnings Per Share (0.08) (0.06)

Contact Information

Contact Name: Alex Abuin
Contact Title: Vice President, Corporate Communications
Phone: 1-281-863-3000

Company Information Yearly Figures Quarterly Figures Contact Information Add To Cart Print